Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 3/20 | 0.73 |
| ▸ | ENPP2 | Q13822 | 7/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
| ▸ | PLG | P00747 | 1/20 | 0.41 |
| ▸ | F12 | P00748 | 1/20 | 0.41 |
| ▸ | F11 | P03951 | 1/20 | 0.41 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5439666 | 0.98 | MGLL (0.70) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL3897261 | 0.88 | MGLL (0.68) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL21125865 | 0.85 | MGLL (0.57) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL66838 | 0.85 | MGLL (1.00) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL29992604 | 0.85 | MGLL (1.00) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL16320930 | 0.84 | MGLL (0.62) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL8158716 | 0.83 | MGLL (0.72) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL31512204 | 0.83 | MGLL (0.56) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL14738438 | 0.83 | MGLL (0.56) | MGLLENPP2CA4CA6CA5A | |
| SCHEMBL29307804 | 0.83 | MGLL (0.51) | MGLLENPP2CA4CA6CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111410967-B | Circular polarization luminous chiral nematic liquid crystal material and preparation method and application thereof | 国家纳米科学中心 | 2022-04-08 | — | — | CN | claimed |
| CN-111410967-A | Circular polarization luminous chiral nematic liquid crystal material and preparation method and application thereof | 国家纳米科学中心 | 2020-07-14 | — | — | CN | claimed |
| US-12167689-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-12-10 | — | — | US | disclosed |
| US-11903311-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-02-13 | — | — | US | disclosed |
| US-20230225206-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-13 | — | — | US | disclosed |
| US-20220336757-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2022-10-20 | — | — | US | disclosed |
| CN-111410967-B | Circular polarization luminous chiral nematic liquid crystal material and preparation method and application thereof | 国家纳米科学中心 | 2022-04-08 | — | — | CN | disclosed |
| EP-3480194-B1 | HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES USING SAME | LG CHEMICAL LTD (KR) | 2021-09-08 | — | — | EP | disclosed |
| CN-111410967-A | Circular polarization luminous chiral nematic liquid crystal material and preparation method and application thereof | 国家纳米科学中心 | 2020-07-14 | — | — | CN | disclosed |
| EP-3480194-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | LG Chem, Ltd. (KR) | 2019-05-08 | — | — | EP | disclosed |
| US-20180337348-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2018-11-22 | — | — | US | disclosed |
| EP-1582516-B1 | Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same | IDEMITSU KOSAN CO (JP) | 2013-07-17 | — | — | EP | disclosed |
| US-7867629-B2 | Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-01-11 | — | — | US | disclosed |
| WO-2010127307-A1 | ANTIMICROBIAL AGENTS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2010-11-04 | — | — | WO | disclosed |
| US-20060154105-A1 | Nitrogenous heterocyclic derivative and organic elecrtroluminescent element employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2006-07-13 | — | — | US | disclosed |
| EP-1582516-A1 | NITROGENOUS HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2005-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230225206-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | NFE2L2, ESR1, OR51E2 | MGLL 2261/4885ENPP2 2414/4885CA4 1806/4885 |
| US-11903311-B2 | Heterocyclic compound and organic light emitting device comprising the same | CYP1A1, CYP1B1, CHRM1 | MGLL 3712/4885ENPP2 2401/4885CA4 3485/4885 |
| US-20180337348-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, ORC3 | MGLL 1895/4885ENPP2 2767/4885CA4 1973/4885 |
| US-12167689-B2 | Heterocyclic compound and organic light emitting device comprising the same | C1S, ARRB1, CRY1 | MGLL 2670/4885ENPP2 2060/4885CA4 3656/4885 |
| US-20220336757-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | C1S, CNR1, ARRB1 | MGLL 2637/4885ENPP2 2439/4885CA4 3558/4885 |
| US-20060154105-A1 | Nitrogenous heterocyclic derivative and organic elecrtroluminescent element employing the same | L1CAM, NOTCH1, NUDC | MGLL 2383/4885ENPP2 2071/4885CA4 2096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.